Overview
Status
Active
Registry date
2016-03-31
Share capital
5,000.00 PLN
Registered address
ul. Powstańców Śląskich 103/1, 01-355 Warszawa, Poland
Financials
Revenue history (in k)
Filing timeliness
No financial statement for 2024 – the filing deadline has passed. 3 of 6 financial statements were filed late (the longest delay 419 days for 2022), 2 not filed.
- 2024not filed
- 202306/09/2024
- 202206/09/2024
- 2021not filed
- 2020not filed
- 201904/03/2020
Filed on timeDelayFiling deadline
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2023.
Results vs industry
Revenue
This companyUSD 144.02kMedianUSD 1.06mAverageUSD 22.40m
Net profit
This companyUSD 44.78kMedianUSD 37.33kAverageUSD 880.24k
Operating costs
This companyUSD 94.67kMedianUSD 922.77kAverageUSD 21.08m
Assets
This companyUSD 131.56kMedianUSD 608.93kAverageUSD 11.85m
Industry
Authorized Representatives
Błażej Stanisław Markwat – President of the Management Board
Manner of representation
Each member of the management board is authorized to make declarations on behalf of the company independently.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
Błażej Stanisław Markwatage 66 | 91 | $1,350.62 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2025-06-21.
05 1600 1462 1739 5556 8000 0001
Debt
No entries in the National Debtors Register (KRZ).
Public aid
| Grant date | Purpose | Gross amount | Granting body | |
|---|---|---|---|---|
| Jul 27, 2020 | Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts | $1,282$1,282 | Prezydent Miasta Stołecznego Warszawy |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Aimedicalsp. z o.o. | $240,059.72 | aimedical.pl | ||
| Vorwarts Pharmasp. z o.o. | $210,138.62 | vorwartspharma.pl | ||
| Black & Whitesp. z o.o. | $154,866.36 | polonus.pl | ||
| Osteoprofsp. z o.o. | $72,065.80 | osteoprof.pl | ||
| THC PharmaS.A. | $39,093.70 | thc-pharma.pl | ||
| EDGE Pharmasp. z o.o. | $19,855.64 | edgepharma.eu | ||
| Arcade Internationalsp. z o.o. | $17,817.26 | arcade-int.pl | ||
| Filicosp. z o.o. | $11,710.75 | filico.eu | ||
| Get Ready Wheelchairssp. z o.o. | $9,842.54 | getreadywheelchairs.com | ||
| Jacek Waksmundzki Trust 2S.K.A. | $5,769.53 | trust.pl |
Change history
| Date | Event | |
|---|---|---|
| 2025-06-02 | Address change (Ul. Badylarska 31, 02-484, Warszawa → Warszawa) | |
| 2020-07-28 | Address change (Ul. Jakobinów 35, 02-240, Warszawa → Ul. Badylarska 31, 02-484, Warszawa) | |
| 2020-07-28 | Name change (Glucoazja → Aquastop) | |
| 2016-07-01 | Address change (Ul. Obrzeżna 5, 02-691, Warszawa → Ul. Jakobinów 35, 02-240, Warszawa) | |
| 2016-07-01 | Name change (Santrax → Glucoazja) |
FAQ
The main business activity of Aquastop focuses on wholesale of pharmaceutical goods.
The company was registered in the Polish National Court Register (KRS) on March 31, 2016.
The headquarters is located at: ul. Powstańców Śląskich 103, 01-355 Warszawa.
The share capital of the company is PLN 5,000 (approx. $1,351).
The latest available financial statement covers the period from January 1, 2023 to December 31, 2023.
In 2023, the company generated total revenue of $144,019.
Yes, in 2023 the company was profitable, achieving a net profit of $44,784.
The largest operating cost category falls under external services. This category amounted to $94,582 in 2023, representing 100% of all operating expenses.
Last updated: 2026-04-20